secwatch.observer — SEC 8-K summary
======================================

Issuer:     ICU MEDICAL INC/DE (ICUI)
CIK:        0000883984
Form:       8-K
Filed at:   2024-10-02T23:59:59+00:00
Accession:  0000883984-24-000032
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ICU Medical appoints Daniel Woolson as President, effective Sept. 30, 2024
--------------------------------------------------------------------------

- Daniel Woolson, 48, appointed President of ICU Medical, effective immediately on Sept. 30, 2024.
- Woolson previously served as Corporate VP and General Manager - Infusion Systems since 2017.
- Prior roles include President, Respiratory Solutions at Becton Dickinson (2015-2016) and VP/GM at CareFusion.
- No departure of current CEO or other officers was announced in connection with this appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883984/000088398424000032/0000883984-24-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883984/000088398424000032/icui-20240930.htm
  HTML page:      https://secwatch.observer/filing/0000883984-24-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer